Guidance for Industry: Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics
Year: 2007
Type: article
Source: Biotechnology Law Report
Language: English
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W4244311468
